1. The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway
    Hongkun Li et al, 2024, Frontiers in Pharmacology CrossRef
  2. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
    Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
  3. Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
    Qian Zuo et al, 2024, Chinese Journal of Integrative Medicine CrossRef
  4. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway
    Huhu Zhang et al, 2023, Journal of Translational Medicine CrossRef
  5. The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents
    Saabira Banu Sahubar Sadik et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
  6. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges
    Chaochao Yu et al, 2022, Journal of Zhejiang University-SCIENCE B CrossRef
  7. Bufalin for an innovative therapeutic approach against cancer
    Laura Soumoy et al, 2022, Pharmacological Research CrossRef
  8. Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells
    Yu Gao et al, 2024, Journal of Liposome Research CrossRef
  9. The multifaceted role of SOX2 in breast and lung cancer dynamics
    Kiavash Hushmandi et al, 2024, Pathology - Research and Practice CrossRef
  10. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC
    Rakshmitha Marni et al, 2023, Life Sciences CrossRef
  11. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development
    Tianshu Zhang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  12. mPEG-Cholic acid/TPGS mixed micelles for combined delivery of paclitaxel and bufalin to treat hepatocellular carcinoma
    Yujia Liu et al, 2022, Pharmaceutical Development and Technology CrossRef